MedTrace Logo

Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy

NCT02679378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2023-02-08

No results posted yet for this study

Summary

Prospective, single-arm, multicenter, open label, non-randomized exploratory clinical study comparing ClearSight system to histopathological to determine negative-margins in breast conserving surgery.

Conditions

Interventions

DEVICE

ClearSight™ System

comparing ClearSight system to histopathological to determine negative-margins in breast conserving surgery.

Sponsors & Collaborators

  • Clear Cut Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr. Christine B. Teal, Dr. · The George Washington University (GWU)

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-12-31
Completion
2018-11-30

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02679378 on ClinicalTrials.gov